Masters in Business cover image

Targeting IgA Nephropathy (Sponsored Content)

Masters in Business

00:00

Therapeutic goal: restore immune balance and remission

Dr. Maskey outlines Vertex’s approach to inhibit both BAFF and APRIL to reduce proteinuria, hematuria, and stabilize kidney function.

Play episode from 15:21
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app